Authors


Anna Wirz-Justice, PhD

Latest:

The Implications of Chronobiology for Psychiatry

Chronobiology-the science of daily (circadian), monthly, tidal, and seasonal rhythms-has undergone exponential growth in the past decade, with major discoveries at the molecular and neuroanatomic level.


Anne Doherty, MBBCh, MedS, MRCPsych

Latest:

Adjustment Disorders: Diagnostic and Treatment Issues

Adjustment disorder is one of the few psychiatric diagnoses for which the etiology, symptoms, and course, rather than symptoms alone, are central to making the diagnosis. Both emotional and behavioral disturbances are present and include low mood, tearfulness, anxiety, self-harm, withdrawal, anger, and irritability.


Anne Fleming, MD, MS

Latest:

Would a Suicide Barrier on the Golden Gate Bridge Save Lives?

The Golden Gate Bridge in San Francisco has the regrettable distinction of being the number one spot for suicide in the world. There have been more than 1300 known suicides from the bridge, and in 2007 at least 35 people committed suicide by jumping off the Golden Gate Bridge, more than in any other year.


Anne L. Foundas, MD

Latest:

Brain Aging and Dementia: Practical Tips From Clinical Research

Age is a major risk factor for the development of Alzheimer disease and other dementias. New technologies in brain imaging represent major advances in our ability to diagnose age-related cognitive and behavioral disorders.


Anne Marie Albano, PhD

Latest:

Social Anxiety in Adolescents

Although social anxiety can be a challenge at any point across the lifespan, it can present a unique set of challenges during the teenage years. More in this podcast.


Anneliese Radke, MSW

Latest:

Treating Adolescent Depression With Psychotherapy: The Three Ts

Despite the high prevalence of depression among youths, there are empirically supported treatments that have been shown to reduce depressogenic symptoms, including the 3 therapies outlined in this article.


Annemone Ligensa

Latest:

The King’s Speech: A Talking Cure for the Stiff Upper Lip

In this blog, Annemone Ligensa reviews The King's Speech from a psychological and historical perspecive.


Annette L. Hanson, MD

Latest:

Did California Dodge a “Right-to-Die” Bullet?

How a radical proposal from California and 3 cases of anorexia nervosa from Colorado exemplify the "slippery slope" of physician-assisted suicide.


Annya Tisher, MD

Latest:

Clinical Assessment of Dysexecutive Syndromes

Dysexecutive syndromes result from damage to the anterior regions of the brain and present as a combination of disinhibition, disorganization, or apathy.


Anonymous

Latest:

Transcending Medicine

Truth be told, gender identity variations are not psychiatric disorders. That said, if you were there, what would you have done?


Anthony Cozzolino, MD

Latest:

Psychiatric Malpractice: Basic Issues in Evolving Contexts

This article focuses on 4 issues in psychiatric malpractice: prescribing, liability for suicide, informed consent, and duty to protect under the Tarasoff v Regents of the University of California ruling. Malpractice is a civil wrong actionable by law. There are 2 goals of malpractice suits: the first is to make an injured plaintiff whole by an award of money, and the second is to inform the profession how courts will decide similar cases in the future.


Anthony Feinstein, MD, PhD

Latest:

Reporting Under Fire: Understanding Psychopathology of War Journalists

The dozens of journalists killed while covering the current war in Iraq gives currency to the dangers encountered by those who bring us the news from the world's conflict zones. Despite the risks inherent in their profession, it is only recently that the psychological health of war reporters has been captured in a systematic and empirical manner.


Anthony J. Levitt, MD, MBBS, FRCPC

Latest:

The Light-er Side of Treating Seasonal Affective Disorder

Seasonal affective disorder affects 1% to 3% of the North American population. Evidence exists for the efficacy of high-intensity bright, fluorescent light. Pharmacological management with SSRIs has shown equivalent efficacy to light therapy. How can these two therapies be combined? What other therapies are available?


Anthony L. Rostain, MD, MA

Latest:

Future ADHD Treatment Options

Experts in attention-deficit/hyperactivity disorder discuss future nonmedication interventions, like trigeminal nerve stimulation and digital therapeutics.


Anthony M. D'agostino, MD

Latest:

Managed Care: The New Colonialism

The term managed care has become the new blasphemy in the health care industry. Symposia, lectures and other presentations on this topic at the 1997 American Psychiatric Association convention all seemed to conclude that managed care in any form is evil and unethical and that by maintaining the moral high ground, physicians holding out against managed care would ultimately win because the cause is just.


Anthony M. Ocana, MD, MSc

Latest:

Deconstructing ADHD, Addiction, and Beyond

News and research highlights on ADHD, conduct disorder, substance use disorder, and behavioral addictions, including compulsive social networking.


Anthony Mannarino, PhD

Latest:

Trauma-Focused Cognitive-Behavioral Therapy for Sexually Abused Children

Cognitive-behavioral therapy can be tailored for use with children who have experienced sexual abuse in order to relieve symptoms of PTSD.


Anthony O. Ahmed, PhD

Latest:

Psychopharmacological Enhancement of Neurocognition in Schizophrenia

This article summarizes efforts to develop neurocognitive enhancement drugs administered individually or as an adjunct to other antipsychotics and cognitive remediation.


Anthony Stern, MD

Latest:

Becoming a Mensch: Timeless Talmudic Ethics for Everyone

The book emerges as a skillful interweaving of 3 elements: an introduction to the Jewish tradition, a set of down-to-earth case examples in practical ethics, and a fine running commentary about Jewish lore and how we can all reflect on it and be enriched by it.


Anthony T. Ng, MD

Latest:

Pandemic Stress Management

Health professionals' emotional reactions to the COVID-19 pandemic range from numbness, anxiety, fear, and rapid shifts to survivor guilt, helplessness, and feelings of detachment. Here: Stress management tactics and what to expect today and beyond.


Anthony W. Bateman, MA, FRCPsych

Latest:

Trait Stages of Diagnosis for Borderline Personality Disorder

The authors describe an alternative model for BPD diagnosis that is dimensional in nature and requires fulfillment of 4 of 7 personality traits.


Anthony Whitaker, MD, JD

Latest:

Assessing Violence Risk in Psychiatric Inpatients: Useful Tools

Psychiatrists who work in inpatient units are faced with daily decisions about predicting which patients will be violent, both in the hospital and after discharge. These decisions are often made using unstructured clinical judgment based on the clinician's experience and knowledge of the literature. How long such judgment stays the standard of care remains to be seen, because psychiatric researchers have produced a number of assessment and management tools to improve the accuracy and use of violence risk assessment. This article briefly outlines 3 tools: the Brøset Violence Checklist (BVC), the Classification of Violence Risk (COVR), and the Historical Clinical Risk-20 (HCR-20).


Antoaneta Balabanov, MD

Latest:

Unrecognized and Untreated: Preventing and Treating Depression in Patients With Epilepsy

The relationship between depression and epilepsy is bidirectional as not only are patients with epilepsy at higher risk of developing depression but patients with depression have a three- to sevenfold higher risk of developing epilepsy. Several studies have found that the presence of depression in patients with intractable epilepsy was a stronger predictor of poor quality of life than the frequency and severity of seizures. The principles of managing depression in epilepsy are reviewed in this article.


Antoine Douaihy, MD

Latest:

The Role of Psychiatrists in HIV Prevention

Because over half of persons with HIV infection have a lifetime history of depression or bipolar disorder, psychiatrists are uniquely positioned to provide both preventive and therapeutic interventions to vulnerable patients.


Anton Porsteinsson, MD

Latest:

Preventing the Onset of Cognitive Decline

By the year 2050, it is estimated that the number of people with Alzheimer disease and other forms of dementia will explode to 36 million in the US and over 160 million worldwide, over 3 times the current rate.


Antonia Baum, MD

Latest:

The Emerging Field of Sports Psychiatry: A New Niche for Psychiatric Practice

There are a number of well-established niches in psychiatry, from forensics to addictions to LGBT. This author relates how she established her niche as a sports psychiatrist.


Antonio Lopez-canino, MD

Latest:

Delirium With Catatonic Features: A New Subtype?

Delirium has been recognized and described since antiquity. It is a brain disturbance manifested by a syndrome of diverse neuro­­psychiatric symptoms. Various terms have been used for delirium, such as acute brain disorder, metabolic enceph­alopathy, organic brain syndrome, and ICU psychosis.


Antonio Mantovani, MD, PhD

Latest:

Applications of Transcranial Magnetic Stimulation to Therapy in Psychiatry

Transcranial magnetic stimulation has been applied in a growing number of psychiatric disorders as a putative treatment. As a focal intervention that may exert lasting effects, TMS offers the hope of targeting underlying circuitry and ameliorating the effects of psychiatric disorders. The ultimate success of such an approach depends upon our knowledge of the neural circuitry involved, on how TMS exerts its effects and on how to control its application to achieve the desired effects. Current challenges in the field include determining how to enhance the efficacy of TMS in these disorders and how to identify patients for whom TMS may be efficacious.


Antonio N. Puente, PhD

Latest:

Update on Psychogenic Nonepileptic Seizures

The authors take an in-depth look at the evaluation, diagnosis, and fundamental treatment recommendations, protocols, and guides to therapy for psychogenic nonepileptic seizures.


Antonio Verdejo-garcía, PhD

Latest:

Novel Therapies for Cognitive Dysfunction Secondary to Substance Abuse

Advances in the fields of neuropsychological assessment and neuroimaging have enormously expanded our knowledge about the profile and severity of cognitive deficits in patients with substance use disorders.

© 2024 MJH Life Sciences

All rights reserved.